Nissui Corporation TSE:1332
Nissui : Financial Statements (November 6, 2025) Consolidated Financial Results
Source: MarketScreener
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
November 6, 2025
Company name: | Nissui Corporation | ||||
Listing: | Tokyo Stock Exchange | ||||
Securities code: | 1332 | ||||
URL: | https://www.nissui.co.jp | ||||
Representative: | Teru Tanaka | Representative Director, President & CEO | |||
Inquiries: | Yoichiro Hiroi | Executive Officer, General Manager of Corporate Strategic Planning & IR Department | |||
Telephone: | +81-3-6206-7037 | ||||
Scheduled date to file semi-annual securities report: | November 13, 2025 | ||||
Scheduled date to commence dividend payments: | December 8, 2025 | ||||
Preparation of supplementary material on financial results: | Yes | ||||
Holding of financial results briefing: | Yes | ||||
(Yen amounts are rounded down to millions, unless otherwise noted.)
- Consolidated financial results for the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025)
- Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Six months ended
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
September 30, 2025
452,943
2.8
19,791
14.6
21,213
11.2
14,296
13.7
September 30, 2024
440,682
8.2
17,276
6.1
19,085
12.1
12,576
7.6
Note: Comprehensive income
For the six months ended September 30, 2025:
¥
9,374 million [
(67.5) %]
For the six months ended September 30, 2024:
¥
28,821 million [
15.9%]
Basic earnings per share
Diluted earnings per share
Six months ended
Yen
Yen
September 30, 2025
46.56
-
September 30, 2024
40.46
-
(Note) In 3Q FY2025/3, provisional accounting treatment for a business combination at an equity-method affiliate was finalized; figures for the interim consolidated period FY2025/3 were restated accordingly.
- Consolidated financial position
Total assets
Net assets
Equity-to-asset ratio
As of
Millions of yen
Millions of yen
%
September 30, 2025
657,016
283,716
41.7
March 31, 2025
634,878
285,939
43.6
Reference: Equity
As of September 30, 2025:
¥
274,280 million
As of March 31, 2025:
¥
277,039 million
- Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
- Cash dividends
Annual dividends per share
First quarter-end
Second quarter-end
Third quarter-end
Fiscal year-end
Total
Yen
Yen
Yen
Yen
Yen
Fiscal year ended
-
12.00
-
16.00
28.00
March 31, 2025
Fiscal year ending
-
14.00
March 31, 2026
Fiscal year ending March 31, 2026
(Forecast)
-
14.00
28.00
Note: Revisions to the forecast of cash dividends most recently announced: None
- Consolidated financial result forecasts for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026)
(Percentages indicate year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Full year | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen |
900,000 | 1.6 | 34,500 | 8.6 | 35,500 | 0.6 | 25,000 | (1.5) | 82.52 | |
Note: Revisions to the financial result forecast most recently announced: None
* Notes(1) Significant changes in the scope of consolidation during the period: | Yes | |||
Newly included: | - | companies( | ) | |
Excluded: | 1 | companies( | Seinan Suisan Co., Ltd. | ) |
(2) Adoption of accounting treatment specific to the preparation of semi-annual consolidated financial statements: | None |
(3) Changes in accounting policies, changes in accounting estimates, and restatement | |||||
(i) | Changes in accounting policies due to revisions to accounting standards and other regulations: | None | |||
(ii) | Changes in accounting policies due to other reasons: | None | |||
(iii) | Changes in accounting estimates: | None | |||
(iv) | Restatement: | None | |||
(4) Number of issued shares (common shares)
(i) Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2025 | 312,430,277 | shares |
As of March 31, 2025 | 312,430,277 | shares |
(ii) | Number of treasury shares at the end of the period | ||
As of September 30, 2025 | 9,157,246 | shares | |
As of March 31, 2025 | 1,607,331 | shares |
(iii) Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Six months ended September 30, 2025 | 307,034,032 | shares |
Six months ended September 30, 2024 | 310,828,242 | shares |
(Note) Nissui has introduced the “Board Benefit Trust (BBT)” as its performance-linked and share-based compensation plan since FY2018 and, from the first quarter of the current consolidated period, has changed to the “Board Benefit Trust-Restricted Stock(BBT-RS).” In addition, its own shares remaining in the Trust is included as treasury shares. The number of treasury stocks at the end of the term was 307,526, and the average number of the term was 543,906.
Semi-annual financial results reports are exempt from review conducted by certified public accountants or an audit firm.
Proper use of earnings forecasts, and other special matters
The performance forecasts in this report are based on information available at present and certain premises thought to be reasonable. Accordingly, the results may change substantially due to various factors. For conditions from which the premises for the forecasts were derived and the other noteworthy items relating to the use of the forecasts, please refer to “ (3) Explanation of Consolidated Financial Forecasts on page 8 of the “1. Qualititaive information for the interiim of the fiscal year ending March 31, 2026.”
Qualitative information for the interim of the fiscal year ending March 31, 2026
In the third quarter of the previous fiscal year, the Company finalized the provisional accounting treatment for a business combination involving an equity-method affiliate. Accordingly, the figures for the interim consolidated period of the previous fiscal year have been restated to reflect that finalization, and these restated amounts are used for comparison and analysis herein. For further details, please refer to “2. Quarterly Consolidated Financial Statements and Primary Notes (4) Notice concerning the consolidated financial statements (Additional Information)”on page 15.
- Explanation of consolidated financial results
During the interim consolidated period, the Japanese economy continued its moderate recovery, driven by increased inbound demand and improvements in employment and income conditions. However, uncertainty persists due to downside economic risks stemming from geopolitical risks and the U.S. tariff policies, as well as consumers growing propensity to cut spending in response to rising prices.
Regarding the global economy (from January to June), a highly uncertain economic environment persisted, as supply and demand fluctuated markedly due to a last-minute surge in demand ahead of planned U.S. tariff hikes and the subsequent reversal.
Under the Medium Term Management Plan “GOOD FOODS Recipe 2, launched in April 2025, our company and its group are reinforcing their business portfolio by pursuing (1) growth in international business, (2) advancement of the aquaculture business, and (3) turnaround of unprofitable operations.
During the interim consolidated period, a delayed recovery in the domestic seafood trading business and higher raw-material costs in the processed foods business weighed on results. Even so, profits improved in the fishery and aquaculture businesses and the North American seafood processing business—both of which had struggled in the previous fiscal year— while the domestic chilled foods business remained firm.
In the current situation, our consolidated business performance for the first quarter cumulative period is as follows: net sales were 452,943 million yen, up 12,260 million yen year-on-year; operating profit was 19,791 million yen, up 2,515 million yen year-on-year; ordinary profit was 21,213 million yen, up 2,128 million yen year-on-year; and profit attributable to owners of parent was 14,296 million yen, up 1,720 million yen year-on-year.
(Unit: million yen)
Net Sales
Operating Profit
Ordinary Profit
Profit attributable to
owners of parent
2Q of FY2025
452,943
19,791
21,213
14,296
2Q of FY2024
440,682
17,276
19,085
12,576
Difference
12,260
2,515
2,128
1,720
Percentage difference (%)
102.8%
114.6%
111.2%
113.7%
The summary by segment is as follows.
(Unit: million yen)
Net Sales
Increase
/Decrease (Y-on-Y)
Y-on-Y
Operating Profit & loss
Increase
/Decrease (Y-on-Y)
Y-on-Y
Marine Products
178,806
3,215
101.8%
6,078
2,566
173.0%
Food Products
251,790
11,931
105.0%
16,830
506
103.1%
Fine Chemicals
7,109
(189)
97.4%
174
69
165.4%
General Distribution
8,356
102
101.2%
1,238
(86)
93.5%
Other (Note)
6,879
(2,800)
71.1%
346
(279)
55.3%
Common Costs
—
—
-%
(4,877)
(261)
105.7%
Total
452,943
12,260
102.8%
19,791
2,515
114.6%
(Note) “Other” refers to Engineering (planning, design, construction of plants and equipment) business, Ship Operation Business, etc.
Marine Products Business
The Marine Products segment is engaged in the fishery, aquaculture, and seafood processing and trading businesses.
We recorded 178,806 million yen (up 3,215 million yen year-on-year) in sales and operating profit of 6,078 million yen (up 2,566 million yen year-on-year) in the Marine Products Business.
Fishery Business: Sales decreased but profit increased year on year. [Japan]
Solid Japanese amberjack and tuna catches drove higher profits.
Aquaculture Business: Sales decreased but profit increased year on year. [Japan]
Although the selling prices of Japanese amberjack and coho salmon increased, competition in tuna intensified due to greater supplies of wild-caught and imported tuna. As a result, overall sales declined, but profits rose.
[South America]
Selling prices rose on a market recovery, and aquaculture performance such as survival rates improved. However, partly due to foreign exchange effects, sales decreased, and profits increased.
Processing and Trading Business: Sales increased but profit decreased year on year. [Japan]
Although sales of Japanese amberjack and other products remained firm, falling fish oil prices, higher raw-material costs for salmon and trout, and a decrease in shrimp sales volume resulted in lower sales and profits.
[North America]
Sales of Alaska pollock fillets and surimi were steady in both volume and price, while trading saw solid sales of cod, salmon and trout, and crab delivering higher sales and profits.
[Europe]
Sales were strong in Italy, the Benelux, and other markets, led by major products such as shrimp and salmon and trout; however, partly due to foreign exchange effects, sales increased while profits decreased.
Food Products Business
The Food Products segment is engaged in the food processing and chilled foods businesses.
We recorded 251,790 million yen (up 11,931 million yen year-on-year) in sales and an operating profit of 16,830 million yen (up 506 million yen year-on-year) in the Food Products Business.
Processed Foods Business: Sales increased, but profit decreased year on year. [Japan]
For household use sales of fish sausages and fish cakes continued to perform well, and food service frozen products for restaurants and supermarket delicatessen counters remained solid. However, higher rice and surimi raw material costs could not be fully offset by price revisions, resulting in lower profits.
[North America]
For household use sales remained firm and expanded market share, while the food service segment struggled amid weaker dining out demand and higher shrimp raw material costs; overall, sales declined but profits increased.
[Europe]
Strong sales in France, the UK and Spain, together with ample inventories of white fish raw materials held ahead of the price increases, generated higher profits.
Chilled Foods Business: Both sales and profits increased year on year.
Effective sales promotions at convenience stores drove continued strong sales of bento, prepared noodles, and delicatessen items, resulting in higher sales and profits.
Fine Chemicals Business
The Fine Chemicals segment is engaged in manufacturing and selling pharmaceutical raw materials, functional raw materials (Note 1), and functional foods (Note 2).
We recorded 7,109 million yen (down 189 million yen year-on-year) in sales and an operating profit of 174 million yen (up 69 million yen year-on-year) in the Fine Chemicals Business.
Domestic sales of functional raw materials for supplements remained firm, —together with pharmaceutical raw materials sales mainly scheduled for the second half—resulted in lower sales and profits.
General Distribution Business
The General Distribution segment is engaged in cold storage, transportation, and customs clearance businesses.
We recorded 8,356 million yen (up 102 million yen year-on-year) in sales and an operating profit of 1,238 million yen (down 86 million yen year-on-year) in the General Distribution Business.
Although the volume handled remained firm and the effects of price revisions were evident, increased personnel expenses associated with additional staffing amid the logistics “2024 problem,” together with higher fuel costs, resulted in higher sales but lower profits.
(Note 1) EPA, DHA, and others mainly used as ingredients in health supplements and infant formula
(Note 2) Supplements such as “Sesame soy milk” functional food and “i-mark S,” food for specified health uses (FOSHU), mainly for online business
- Explanation of the consolidated financial position
State of assets, liabilities, and net assets
(Unit: million yen)
AssetsFY2024
2Q of FY2025
Increase/Decrease
Current Assets
332,568
344,412
11,844
(Inventories)
195,008
198,336
3,327
Non-current Assets
302,309
312,603
10,293
Total Assets
634,878
657,016
22,137
Current Liabilities
226,179
232,895
6,715
Non-current Liabilities
122,758
140,403
17,644
Total Liabilities
348,938
373,299
24,360
Total Net Assets
285,939
283,716
(2,223)
Total assets increased by 22,137 million yen to 657,016 million yen compared to the end of the previous consolidated fiscal year (up 3.5 %).
Current assets increased by 11,844 million yen to 344,412 million yen (up 3.6%). This is mainly because cash and deposits increased by 4,995 million yen, the inventory increased by 3,327 million yen, in addition to notes and accounts receivable increased by 2,843 million yen due to increased sales.
Non-current assets increased by 10,293 million yen to 312,603 million yen (up 3.4%), mainly due to increased property, plant, and equipment costs by 7,433 million yen of capital investment.
LiabilitiesTotal liabilities increased by 24,360 million yen to 373,299 million yen compared to the end of the previous consolidated fiscal year (up 7.0%).
Current liabilities increased by 6,715 million yen to 232,895 million yen (up 3.0%), mainly because of increased short-term borrowings by 7,735 million yen due to increased demand for working capital.
Non-current liabilities increased by 17,644 million yen to 140,403 million yen (up 14.4%). The main reason was an increase in long-term borrowings by 17,032 million yen.
Net AssetsTotal net assets decreased by 2,223 million yen to 283,716 million yen compared to the end of the previous consolidated fiscal year (down 0.8%). This is mainly due to posting a profit attributable to owners of the parent of 14,296 million yen, paying surplus dividends by 4,985 million yen, and decreasing foreign currency translation adjustment by 6,727 million yen due to the weak yen. Also, there was an increase in treasury stock by 5,861 million yen mainly due to the tender offer.
State of cash flows
(Unit: million yen)
2Q of FY2024
2Q of FY2025
Increase
/Decrease
Net cash provided by operating activities
13,406
16,543
3,137
Net cash used in investing activities
(16,308)
(25,633)
(9,324)
Net cash provided by financing activities
2,359
14,446
12,086
Cash and cash equivalent at the end of period
20,034
23,843
3,809
Net cash flows provided by operating activities were 16,543 million yen (increased by 3,137 million yen compared to the same period of the previous year). This was due to the total interim net profit and depreciation expense before adjustment for taxes and other expenses were 33,742 million yen. Meanwhile, the decrease in funds due to an increase in inventory was 11,292 million yen, and the amount paid for corporate tax was 4,218 million yen.
Net cash flows used in investment activities were 25,633 million yen (increased by 9,324million yen compared to the same period of the previous year). This was mainly due to the expenditure of 24,356 million yen related to acquiring property, plant, and equipment associated with investments in production facilities in Japan and overseas.
Net cash flows provided by financing activities were 14,446 million yen (increased by 12,086 million compared to the same period of the previous year). This was due to an increase in short-term borrowings of 26,862 million yen, while dividends paid were 4,978 million yen and expenditure f rom treasury stock acquisitions was 6,073 million yen.
- Explanation of Consolidated Financial Forecasts
Regarding the full-year earnings forecast and dividend forecast, we do not change the forecast announced on May 14, 2025.
- Explanation of consolidated financial results
Semi-annual Consolidated Financial Statements and Primary Notes
Semi-annual Consolidated Balance Sheet
(Millions of yen)
As of March 31, 2025
As of September 30, 2025
Assets
Current assets
Cash and deposits
14,707
19,703
Notes and accounts receivable - trade
107,400
110,243
Merchandise and finished goods
102,564
103,100
Work in process
33,172
36,611
Raw materials and supplies
59,271
58,624
Other
16,067
16,674
Allowance for doubtful accounts
(616)
(545)
Total current assets
332,568
344,412
Non-current assets
Property, plant and equipment
Buildings and structures, net
68,204
66,649
Other, net
112,734
121,722
Total property, plant and equipment
180,939
188,372
Intangible assets
Goodwill
2,120
1,844
Other
14,929
14,039
Total intangible assets
17,050
15,884
Investments and other assets
Investment securities
30,453
32,608
Shares of subsidiaries and associates
49,398
49,685
Long-term loans receivable
8,158
9,315
Retirement benefit asset
330
224
Deferred tax assets
4,489
3,778
Other
12,695
13,966
Allowance for doubtful accounts
(1,204)
(1,232)
Total investments and other assets
104,320
108,346
Total non-current assets
302,309
312,603
Total assets
634,878
657,016
(Millions of yen)
As of March 31, 2025
As of September 30, 2025
Liabilities
Current liabilities
Notes and accounts payable - trade
56,439
56,966
Short-term borrowings
114,104
121,840
Income taxes payable
3,639
4,867
Accrued expenses
29,121
27,416
Provisions
4,436
4,400
Other
18,437
17,403
Total current liabilities
226,179
232,895
Non-current liabilities
Long-term borrowings
95,832
112,865
Provisions
249
105
Retirement benefit liability
7,694
7,272
Other
18,981
20,159
Total non-current liabilities
122,758
140,403
Total liabilities
348,938
373,299
Net assets
Shareholders' equity
Share capital
30,685
30,685
Capital surplus
21,833
21,844
Retained earnings
171,996
181,307
Treasury shares
(708)
(6,569)
Total shareholders' equity
223,806
227,268
Accumulated other comprehensive income
Valuation difference on available-for-sale securities
12,969
14,536
Deferred gains or losses on hedges
881
(415)
Foreign currency translation adjustment
40,938
34,210
Remeasurements of defined benefit plans
(1,555)
(1,318)
Total accumulated other comprehensive income
53,233
47,012
Non-controlling interests
8,900
9,436
Total net assets
285,939
283,716
Total liabilities and net assets
634,878
657,016
Semi-annual Consolidated Statements of Income and Comprehensive Income
Semi-annual Consolidated Statement of Income
(Millions of yen)
For the six months ended September 30, 2024
For the six months ended September 30, 2025
Net sales
440,682
452,943
Cost of sales
369,945
378,532
Gross profit
70,737
74,410
Selling, general and administrative expenses
53,461
54,618
Operating profit
17,276
19,791
Non-operating income
Interest income
265
298
Dividend income
408
480
Share of profit of entities accounted for using equity method
2,512
1,129
Subsidy income
78
723
Miscellaneous income
344
304
Total non-operating income
3,609
2,936
Non-operating expenses
Interest expenses
1,608
1,418
Foreign exchange losses
20
0
Miscellaneous expenses
171
95
Total non-operating expenses
1,800
1,514
Ordinary profit
19,085
21,213
Extraordinary income
Gain on sale of non-current assets
111
412
Gain on sale of investment securities
122
-
Gain on bargain purchase
151
-
Gain on liquidation of subsidiaries and associates
81
-
Total extraordinary income
466
412
Extraordinary losses
Loss on disposal of non-current assets
235
265
Impairment losses
-
76
Loss on valuation of investment securities
95
4
Loss on disaster
236
181
Total extraordinary losses
567
527
Profit before income taxes
18,983
21,098
Income taxes - current
5,386
6,068
Income taxes - deferred
48
(435)
Total income taxes
5,435
5,632
Profit
13,548
15,465
Profit attributable to non-controlling interests
972
1,169
Profit attributable to owners of parent
12,576
14,296
Semi-annual Consolidated Statement of Comprehensive Income
(Millions of yen)
For the six months ended September 30, 2024
For the six months ended September 30, 2025
Profit
13,548
15,465
Other comprehensive income
Valuation difference on available-for-sale securities
(884)
1,251
Deferred gains or losses on hedges
(550)
(1,728)
Foreign currency translation adjustment
14,579
(6,266)
Remeasurements of defined benefit plans, net of tax
(540)
249
Share of other comprehensive income of entities
accounted for using equity method
2,668
403
Total other comprehensive income
15,272
(6,091)
Comprehensive income
28,821
9,374
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
27,846
8,076
Comprehensive income attributable to non-controlling
interests
974
1,298
Semi-annual Consolidated Statement of Cash Flows
(Millions of yen)
For the six months ended September 30, 2024
For the six months ended September 30, 2025
Cash flows from operating activities
Profit before income taxes
18,983
21,098
Depreciation
12,055
12,644
Impairment losses
-
76
Amortization of goodwill
330
296
Increase (decrease) in allowance for doubtful accounts
(11)
(68)
Increase (decrease) in retirement benefit liability
(591)
92
Interest and dividend income
(674)
(778)
Interest expenses
1,608
1,418
Share of loss (profit) of entities accounted for using
equity method
(2,512)
(1,129)
Gain on sale of non-current assets
(111)
(412)
Loss on disposal of noncurrent assets
235
265
Loss (gain) on sale and valuation of investment securities
(27)
4
Loss on disaster
-
181
Decrease (increase) in trade receivables
4,495
(4,824)
Decrease (increase) in inventories
(4,076)
(7,044)
Increase (decrease) in trade payables
(1,251)
1,953
Increase (decrease) in accrued expenses
(6,253)
(1,377)
Other, net
(88)
(1,860)
Subtotal
22,111
20,536
Interest and dividends received
712
1,107
Interest paid
(1,651)
(1,297)
Proceeds from insurance income
-
415
Income taxes paid
(7,766)
(4,218)
Net cash provided by (used in) operating activities
13,406
16,543
Cash flows from investing activities
Decrease (increase) in time deposits
(105)
(0)
Purchase of property, plant and equipment
(14,098)
(24,356)
Proceeds from sale of property, plant and equipment
154
533
Purchase of intangible assets
(533)
(488)
Purchase of investment securities
(391)
(213)
Proceeds from sale of investment securities
224
0
Payments for acquisition of businesses
(403)
-
Proceeds from purchase of shares of subsidiaries
resulting in change in scope of consolidation
89
-
Decrease (increase) in short-term loans receivable
254
(58)
Long-term loan advances
(7)
(2,529)
Income from compensation
-
3,203
Other, net
(1,491)
(1,723)
Net cash provided by (used in) investing activities
(16,308)
(25,633)
(Millions of yen)
For the six months ended September 30, 2024
For the six months ended September 30, 2025
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
10,714
26,862
Proceeds from long-term borrowings
675
18,000
Repayments of long-term borrowings
(3,568)
(18,030)
Repayments of lease liabilities
(449)
(618)
Dividends paid
(4,355)
(4,978)
Dividends paid to non-controlling interests
(653)
(715)
Decrease (increase) in treasury shares
(2)
(6,073)
Net cash provided by (used in) financing activities
2,359
14,446
Effect of exchange rate change on cash and cash equivalents
1,043
(199)
Net increase (decrease) in cash and cash equivalents
500
5,157
Cash and cash equivalents at beginning of period
19,533
18,686
Cash and cash equivalents at end of period
20,034
23,843
- Notice concerning the consolidated financial statements
(Notes on Going Concern) Not applicable.
(Notes Regarding Significant Changes in the Amount of Shareholders’ Equity)
At the Board of Directors meeting held on May 14, 2025, the Company resolved, pursuant to Article 156, Paragraph 1 of the Companies Act as applied by replacing the terms pursuant to Article 165, Paragraph 3 of the same Act and in accordance with the Company’s Articles of Incorporation, to acquire its own shares through a tender offer. As a result, on July 3, 2025, the Company acquired 7,864,875 shares of treasury stock.
Mainly due to this acquisition, treasury stock increased by 5,861 million yen, resulting in a balance of 6,569 million yen at the end of the interim of the current consolidated fiscal period.
(Additional Information)
(Finalization of Provisional Accounting Treatment for Equity-Method Investments)
Provisional accounting treatment was applied to an equity-method affiliate acquired through a business combination in the interim of the previous consolidated fiscal year It was finalized in the third quarter of the previous consolidated fiscal year.
Following this finalization, the equity-method affiliate recorded a gain on negative goodwill. Accordingly, the comparative information presented in the quarterly consolidated financial statements for the interim of the previous fiscal year has been revised.
As a result, in the consolidated statement of income for the interim of the previous fiscal year, the share of profit of entities accounted for using the equity method increased by 2,108 million yen, and the income taxes deferred increased by 31 million yen. In addition to these changes, the share of other comprehensive income of entities accounted for using the equity method increased by 143 million yen in the consolidated statement of comprehensive income.
(Segment Information, etc.)
- 2nd Quarter of the previous Fiscal Year (April 1, 2024, September 30, 2024)
Information on net sales and profit (loss) by reportable segment
(Unit: Million yen)
Information by business segments
Other (Note1)
Total
Adjustement (Note 2)
Consolidated (Note.3)
Marine
Products
Food
Products
Fine
Chemicals
General
Distribution
Total
Sales
175,590
9,081
239,858
485
7,298
256
8,253
6,674
431,002
16,499
9,680
848
440,682
17,347
-(17,347)
440,682
-
Total
184,672
240,344
7,555
14,928
447,501
10,528
458,030
(17,347)
440,682
Segment income
3,512
16,323
105
1,324
21,266
625
21,892
(4,616)
17,276
Sales to third parties
Inter-segment sales and transfers
(Note)
The “Other” segment includes the building/repairing of ships, engineering, operation, and other businesses not included in the reportable segments.
The (4,616) million yen segment profit adjustment comprises 61 million yen in inter-segment eliminations and (4,677) million yen in corporate expenses not allocated to the segments. Corporate expenses are mainly comprised of selling, general, and administrative expenses not allocated to the segments.
Segment income is adjusted to reflect operating profit as the interim income statement records.
Information regarding impairment loss on non-current assets and goodwill by reportable segment
(Significant impairment loss on non-current assets) Not applicable.
(Significant changes in the amount of goodwill)
Not applicable.
(Significant gain on negative goodwill) Not applicable.
- 2nd Quarter of the current Fiscal Year (April 1, 2025 -September 30, 2025)
Information on net sales and profit (loss) by reportable segment
(Unit: Million yen)
Information by business segments
Other (Note1)
Total
Adjustement
(Note 2)
Consolidated (Note.3)
Marine
Products
Food
Products
Fine
Chemicals
General
Distribution
Total
Sales
178,806
8,117
251,790
1,656
7,109
207
8,356
7,143
446,063
17,125
6,879
371
452,943
17,496
-(17,496)
452,943
-
Total
186,924
253,447
7,316
15,500
463,188
7,251
470,439
(17,496)
452,943
Segment income
6,078
16,830
174
1,238
24,322
346
24,668
(4,877)
19,791
Sales to third parties
Inter-segment sales and transfers
(Note)
The “Other” segment includes the building/repairing of ships, engineering, operations, and other businesses not included in the reportable segments.
The (4,877) million yen segment income adjustment comprises 58 million yen in inter-segment transactions and (4,935) million yen in corporate expenses not allocated to the segments. Corporate expenses are mainly comprised of selling, general, and administrative costs not allocated to the segments.
Segment income is adjusted to reflect operating profit in the interim income statement.
Information regarding impairment loss on non-current assets and goodwill by reportable segment (Significant impairment loss on non-current assets)
- 2nd Quarter of the previous Fiscal Year (April 1, 2024, September 30, 2024)
Disclosure is omitted due to immateriality.
(Significant changes in the amount of goodwill) Not applicable.
(Significant gain on negative goodwill) Not applicable.